Shkreli Seeks High Court Review Of Securities Fraud Conviction
WASHINGTON, D.C. — Review of a federal appellate panel’s ruling addressing the correctness of a “no ultimate harm” (NUH) jury instruction in the conviction of former pharmaceutical company CEO and hedge...To view the full article, register now.
Already a subscriber? Click here to view full article